PT - JOURNAL ARTICLE AU - Cao, Longbing AU - Liu, Qing TI - COVID-19 Modeling: A Review AID - 10.1101/2022.08.22.22279022 DP - 2022 Jan 01 TA - medRxiv PG - 2022.08.22.22279022 4099 - http://medrxiv.org/content/early/2022/08/23/2022.08.22.22279022.short 4100 - http://medrxiv.org/content/early/2022/08/23/2022.08.22.22279022.full AB - The unprecedented and overwhelming SARS-CoV-2 virus and COVID-19 disease significantly challenge our life and the society and economy. Many questions emerge, a critical one is to quantify the challenges, realities, intervention effect and influence of the pandemic. With the massive effort in modeling COVID-19, what COVID-19 issues have been modeled? what and how well have epidemiology, AI, data science, machine learning, deep learning, mathematics and social science characterized the COVID-19 epidemic? what are the gaps and opportunities of quantifying the pandemic? Such questions involve a wide body of knowledge and literature, unclear but important for the present and future health crisis quantification. Here, we provide a comprehensive review of the challenges, tasks, methods, progress, gaps and opportunities in relation to modeling COVID-19 processes, data, mitigation and impact. With a research landscape of COVID-19 modeling, we further categorize, summarize, compare and discuss the related methods and progress of modeling COVID-19 epidemic transmission processes and dynamics, case identification and tracing, infection diagnosis and medical treatments, non-pharmaceutical interventions and their effects, drug and vaccine development, psychological, economic and social influence and impact, and misinformation, etc. The review shows how modeling methods such as mathematical and statistical models, domain-driven modeling by epidemiological compartmental models, medical and biomedical analysis, AI and data science in particular shallow and deep machine learning, simulation modeling, social science methods and hybrid modeling have addressed the COVID-19 challenges and what gaps and directions exist for better futures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAustralian Research Council Discovery grant DP190101079 and the ARC Future Fellowship grant FT190100734Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript with further information available at https://datasciences.org/covid19-modeling/. https://datasciences.org/covid19-modeling/